Literature DB >> 24700780

Solution structure of the major factor VIII binding region on von Willebrand factor.

Nuha Shiltagh1, John Kirkpatrick1, Lisa D Cabrita1, Tom A J McKinnon2, Konstantinos Thalassinos1, Edward G D Tuddenham3, D Flemming Hansen1.   

Abstract

Although much of the function of von Willebrand factor (VWF) has been revealed, detailed insight into the molecular structure that enables VWF to orchestrate hemostatic processes, in particular factor VIII (FVIII) binding and stabilization in plasma, is lacking. Here, we present the high-resolution solution structure and structural dynamics of the D' region of VWF, which constitutes the major FVIII binding site. D' consists of 2 domains, trypsin-inhibitor-like (TIL') and E', of which the TIL' domain lacks extensive secondary structure, is strikingly dynamic and harbors a cluster of pathological mutations leading to decreased FVIII binding affinity (type 2N von Willebrand disease [VWD]). This indicates that the backbone malleability of TIL' is important for its biological activity. The principal FVIII binding site is localized to a flexible, positively charged region on TIL', which is supported by the rigid scaffold of the TIL' and E' domain β sheets. Furthermore, surface-charge mapping of the TIL'E' structure reveals a potential mechanism for the electrostatically guided, high-affinity VWF⋅FVIII interaction. Our findings provide novel insights into VWF⋅FVIII complex formation, leading to a greater understanding of the molecular basis of the bleeding diathesis type 2N VWD.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700780      PMCID: PMC4073327          DOI: 10.1182/blood-2013-07-517086

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

Review 1.  Dipolar couplings in macromolecular structure determination.

Authors:  A Bax; G Kontaxis; N Tjandra
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

2.  Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.

Authors:  S Allen; A M Abuzenadah; J L Blagg; J Hinks; I M Nesbitt; A C Goodeve; T Gursel; J Ingerslev; I R Peake; M E Daly
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

3.  Determination of Leu side-chain conformations in excited protein states by NMR relaxation dispersion.

Authors:  D Flemming Hansen; Philipp Neudecker; Pramodh Vallurupalli; Frans A A Mulder; Lewis E Kay
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

Review 4.  The international society on thrombosis and haematosis von Willebrand disease database: an update.

Authors:  Daniel J Hampshire; Anne C Goodeve
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

5.  Contributions to protein entropy and heat capacity from bond vector motions measured by NMR spin relaxation.

Authors:  D Yang; Y K Mok; J D Forman-Kay; N A Farrow; L E Kay
Journal:  J Mol Biol       Date:  1997-10-10       Impact factor: 5.469

6.  Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.

Authors:  T N Mayadas; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Sequence and structure relationships within von Willebrand factor.

Authors:  Yan-Feng Zhou; Edward T Eng; Jieqing Zhu; Chafen Lu; Thomas Walz; Timothy A Springer
Journal:  Blood       Date:  2012-04-06       Impact factor: 22.113

8.  Factor VIII recombination after dissociation by CaCl12.

Authors:  H A Cooper; T R Griggs; R H Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.

Authors:  E G Tuddenham; R S Lane; F Rotblat; A J Johnson; T J Snape; S Middleton; P B Kernoff
Journal:  Br J Haematol       Date:  1982-10       Impact factor: 6.998

10.  Identification of disulfide-bridged substructures within human von Willebrand factor.

Authors:  T Marti; S J Rösselet; K Titani; K A Walsh
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

View more
  17 in total

1.  Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.

Authors:  Andrew Yee; Austin N Oleskie; Anne M Dosey; Colin A Kretz; Robert D Gildersleeve; Somnath Dutta; Min Su; David Ginsburg; Georgios Skiniotis
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 2.  Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors:  Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal:  Blood       Date:  2016-09-01       Impact factor: 22.113

3.  Functional characterisation of the type 1 von Willebrand disease candidate VWF gene variants: p.M771I, p.L881R and p.P1413L.

Authors:  Ergul Berber; Mehmet Ozbil; Christine Brown; Zafer Baslar; S Hande Caglayan; David Lillicrap
Journal:  Blood Transfus       Date:  2016-07-25       Impact factor: 3.443

Review 4.  von Willebrand factor, Jedi knight of the bloodstream.

Authors:  Timothy A Springer
Journal:  Blood       Date:  2014-06-13       Impact factor: 22.113

5.  The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.

Authors:  Xianchi Dong; Nina C Leksa; Ekta Seth Chhabra; Joseph W Arndt; Qi Lu; Kevin E Knockenhauer; Robert T Peters; Timothy A Springer
Journal:  Blood       Date:  2019-01-14       Impact factor: 22.113

Review 6.  Acquired von Willebrand syndrome associated with left ventricular assist device.

Authors:  Angelo Nascimbene; Sriram Neelamegham; O H Frazier; Joel L Moake; Jing-Fei Dong
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

7.  Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.

Authors:  Emma-Ruoqi Xu; Sören von Bülow; Po-Chia Chen; Peter J Lenting; Katra Kolšek; Camilo Aponte-Santamaría; Bernd Simon; Jaelle Foot; Tobias Obser; Reinhard Schneppenheim; Frauke Gräter; Cécile V Denis; Matthias Wilmanns; Janosch Hennig
Journal:  Blood       Date:  2018-10-10       Impact factor: 22.113

8.  The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.

Authors:  Ian W Smith; Anne E d'Aquino; Christopher W Coyle; Andrew Fedanov; Ernest T Parker; Gabriela Denning; Harold Trent Spencer; Pete Lollar; Christopher B Doering; Paul Clint Spiegel
Journal:  J Thromb Haemost       Date:  2019-09-08       Impact factor: 5.824

9.  Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice.

Authors:  Xin Xu; Chenyu Wang; Yingang Wu; Katie Houck; Tristan Hilton; Ashley Zhou; Xiaoping Wu; Cha Han; Mengchen Yang; Wei Yang; Fu-Dong Shi; Moritz Stolla; Miguel A Cruz; Min Li; Jianning Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2021-01-28       Impact factor: 25.476

10.  Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.

Authors:  James R Fuller; Kevin E Knockenhauer; Nina C Leksa; Robert T Peters; Joseph D Batchelor
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.